EPIS_B: Transformation to a property-focused company drove strong sales growth but higher losses

About this update from Episurf Medical Ab Class B

Q1 2026 marked a strategic shift toward property operations, with net sales up 252% year-over-year and major acquisitions completed or signed. Operating loss widened due to transaction and medtech costs, but equity ratio improved to 76.8%.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Episurf Medical Ab Class B